This requirement was for a FDA Approved Flow Cytometry Instrumentation must be able to have fully automated discrete random-access capabilities; be able to store reagents at the Food and Drug Administration (FDA) storage levels; be capable of barcode identification; be able to print patient results as one per page; have the ability to interface with the Military Health System (MHS) Genesis and the Risk Management Framework (RMF) and Health Insurance Portability and Accountability Act (HIPAA) compliant.
The Department of DEFENSE está buscando respuestas para in-vitro diagnostic substance manufacturing en JBSA FT SAM HOUSTON, TX.
¿Buscas más oportunidades?
Explora nuestro directorio completo de contratos gubernamentales